Browsing Tag
Cell
1 post
Atrogi’s ATR-258 breakthrough: muscle-targeted β2-agonist mimics exercise to treat obesity, diabetes, and muscle loss
Atrogi’s ATR-258 mimics exercise through skeletal muscle targeting to reduce fat and preserve muscle, redefining obesity and diabetes therapies.